Exploring New Therapeutic Pathways in Pulmonary Hypertension. Metabolism, Proliferation, and Personalized Medicine
Year: 2020
Type: article
Abstract: In this review, we explore the main themes from the 62nd Annual Aspen Lung Conference (hypoxia, cellular metabolism, inflammatory pathways, aberrant proliferation, and personalized medicine) and highlight challenges and opportunities in the coming decade of pulmonary vascular disease.
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: 1/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial), Therapeutic Targeting of Vascular Subphenotypes of Lung Disease, Complement Mediated Remodeling in Pulmonary Vascular Disease, 2019 Aspen Lung Conference: Exploring new therapeutic pathways in pulmonary hypertension: metabolism, proliferation, and personalized medicine, Adaptation to Hypoxia, Activation, Phenotype and Function of CD4 T Cells in Schistosoma-Pulmonary Hypertension, Antidote for inhaled CO poisoning based on mutationally engineered neuroglobin, Omics, mice and men: Development of precision transfusion medicine, Training in Translational Research in Pulmonary Vascular Biology
OpenAlex ID: W3032872731